A Study on M2a Magnum Total Hip Arthroplasty

A Prospective Controlled Multi-Center Study on M2a Magnum Total Hip Arthroplasty

The purpose of this study includes the investigation of Metal-ion release and Renal Function analysis in M2a Total Hip Arthroplasty.

There are no clinical studies conducted on its performance in Asian population. Furthermore clinical data is required to support marketing and validate design of M2A Magnum.

Inclusion Criteria:

• Patients suitable for primary Total Hip Replacement
• Patients aged over 20
• Patients with limited co-morbidity- ASA I-III
• Patients must be able to understand instructions and be willing to return for follow-up
• Patients willing to provide blood and urine samples for metal ion analysis at follow-up

Exclusion Criteria:

• Pre-existing metal implants
• Infection, sepsis, and osteomyelitis
• Uncooperative patient or pt with neurologic disorders who are incapable of following directions
• Osteoporosis
• Metabolic disorders which may impair bone formation
• osteomalacia
• distant foci of infections which may spread to the implant site
• rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
• vascular insufficiency, muscular atrophy, or neuromuscular disease
• pregnancy